UNSPSC 51284139: Cefpodoxime proxetil

This classification denotes a cephalosporin antibiotic C21H27N5O9S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2TB00A1Z7N, chemically known as (+/-)-1-hydroxyethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7 (sup 2)-(z)-(o-methyloxime), isopropyl carbonate (ester), but more generally known as cefpodoxime proxetil, which bears US NIH Compound Identifier 6526396.

UNSPSC 51284139 Cefpodoxime proxetil, a Commodity code, shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific antibiotic pharmaceutical product, but the recent opportunities tagged under it involve naloxone procurement, medical and first aid supplies for emergency response, direct-to-manufacturer pharmacy initiatives, and generic multi-source pharmaceutical contracting—none of which specifically target cefpodoxime proxetil or narrow-spectrum antibiotic procurement. The issuing bodies soliciting under this code span county health departments, municipal fire departments, state health agencies, and cooperative purchasing alliances, but the work being purchased diverges substantially from the code's nominal scope. The mismatch suggests either systematic miscoding in source databases or that cefpodoxime proxetil itself is not a focal procurement category in recent state and local activity.

The geographic spread includes Florida (Seminole County naloxone procurement), Texas (HHS Commission pharmacy initiative RFI), Florida (City of Tampa medical supplies), and Minnesota (MMCAP cooperative purchasing for multi-source generics and OTC products). Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for naloxone and drug deactivation systems; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies with a $700,000 estimated contract value and SLBE set-aside; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic pharmaceuticals and OTC products through authorized wholesalers. The code shows little relevant recent activity for cefpodoxime proxetil specifically.